Drugs Online » Prescription Drugs 4 » Cellcept Generic Mycophenolate Mofetil
CellCept is used for: Preventing organ rejection following kidney liver or heart transplants. This medicine is used in combination with other medicines. Mycophenolate (mye-koe-FEN-oh-late) belongs to a group of medicines known as immunosuppressive agents. It is used to lower the body's natural immunity in patients who receive organ transplants. CellCept is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal cardiac or hepatic transplants. CellCept should be used concomitantly with cyclosporine and corticosteroids.When a patient receives an organ transplant the body's white blood cells will try to get rid of (reject) the transplanted organ. Mycophenolate works by preventing the white blood cells from getting rid of the transplanted organ.
Buy Cellcept Generic Mycophenolate Mofetil and other Prescription Drugs 4 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Cellcept Generic Mycophenolate Mofetil:
Product Type: Prescription Drugs 4
Cellcept ( Generic Mycophenolate Mofetil )
Cellcept (Generic Mycophenolate Mofetil)
Generic Mycophenolate Mofetil
250mg 100 Capsules 500mg 50 Capsules
Generic Mycophenolate Mofetil Cellcept

View more
Prescription Drugs 4
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|